Trending

NICE allows immunotherapy treatment for small group of patients with advanced triple negative breast cancer

The company’s list price is £2630 per 100 mg solution for infusion vial but the drug is made available to the NHS with a confidential discount. Breast cancers that test negative for oestrogen and progesterone receptors and …

Read more at www.bmj.com

Show More

Related Articles

Back to top button